251 filings
Page 2 of 13
8-K
1dxro7 nh
7 Nov 23
Xencor Reports Third Quarter 2023 Financial Results
4:04pm
8-K
azxhvolpyg9xfy8wkpa
7 Nov 23
Entry into a Material Definitive Agreement
4:03pm
8-K
z9lf7
26 Oct 23
Xencor Announces Planned Retirement of Chief Financial Officer John Kuch
8:11am
8-K
knr8r0go4yec6ilffc8
19 Sep 23
Xencor Appoints Barbara J. Klencke, M.D., to Board of Directors
4:31pm
8-K
8nh q8o08
3 Aug 23
Xencor Reports Second Quarter 2023 Financial Results
4:02pm
8-K
dm7gaq5t l4tv
3 Jul 23
Departure of Directors or Certain Officers
7:16am
S-8
3zi 7fpfo7
16 Jun 23
Registration of securities for employees
10:54am
S-8 POS
3rihvyknz4jbxcet
16 Jun 23
Registration of securities for employees (post-effective amendment)
10:41am
S-8 POS
hjccn leg4p0
16 Jun 23
Registration of securities for employees (post-effective amendment)
10:37am
S-8 POS
7o2 m0tx0i3fr
16 Jun 23
Registration of securities for employees (post-effective amendment)
10:28am
S-8 POS
f1drh9d6ulh pt
15 Jun 23
Registration of securities for employees (post-effective amendment)
6:52pm
8-K
xb91irbajj
14 Jun 23
Submission of Matters to a Vote of Security Holders
5:55pm
8-K
v92od
8 May 23
Xencor Reports First Quarter 2023 Financial Results
4:44pm
DEFR14A
idmkv5q1enp571t5
1 May 23
Revised proxy
4:15pm
ARS
vwjl9i5qdjbb7zezq
26 Apr 23
Annual report to shareholders
5:19pm
DEFA14A
hyn7k4jqcqh8nm
26 Apr 23
Additional proxy soliciting materials
4:19pm
8-K
2tz7e4qwfab
26 Apr 23
Xencor Appoints Nancy Valente, M.D., as Chief Development Officer
8:52am